Elizabeth Graver (@ekg_pharmd) 's Twitter Profile
Elizabeth Graver

@ekg_pharmd

Pediatric Oncology and BMT Pharmacist🎗️@MDAndersonNews | MD Anderson residency trained | PharmD @UTexasPharmacy

ID: 1374228746442510342

calendar_today23-03-2021 05:17:27

77 Tweet

224 Followers

253 Following

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives. 1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.

Elizabeth Graver (@ekg_pharmd) 's Twitter Profile Photo

Best way to end Midyear? Finding out you get to stay at your favorite place and continue residency training as a PGY2 in oncology. 😍 MD Anderson Cancer Center #ASHP22

Best way to end Midyear? Finding out you get to stay at your favorite place and continue residency training as a PGY2 in oncology. 😍 <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>  #ASHP22
Ryan Marino is on BlueSky (@ryanmarino) 's Twitter Profile Photo

If you could overdose on fentanyl just by touching it or being near it then people wouldn’t be injecting it. And every medical center would be a mass casualty. Signed, Someone who administered fentanyl safely and therapeutically today with no adverse effects to anyone involved.

Dr. Glaucomflecken (@dglaucomflecken) 's Twitter Profile Photo

Cigna uses an automated system that allows “medical directors” (doctors employed by Cigna Healthcare) to deny a claim in 1.2 seconds without opening the patient’s file. Please read this, share it, and help us (metaphorically) burn these companies to the ground.

Adam Grant (@adammgrant) 's Twitter Profile Photo

People who are unwilling to admit their mistakes are unable to learn from them. Acknowledging yesterday's error is a prerequisite to correcting it today and preventing more tomorrow. When we get it wrong, arrogance insists "I was right." Humility says "I want to make it right."

Aaron Goodman - “Papa Heme” (@aarongoodman33) 's Twitter Profile Photo

When ever I see a new patient in oncology clinic I try to remind myself right before opening the clinic room door that right now is likely one of the worst/scariest/anxiety provoking days of their life. Then I go in the room.

Elizabeth Graver (@ekg_pharmd) 's Twitter Profile Photo

Added a little ✨spice✨ to my first drug class oncology forum presentation with some anthracycline themed sugar cookies 🧬 #topo2inhibitors #cardiotoxicity

Added a little ✨spice✨ to my first drug class oncology forum presentation with some anthracycline themed sugar cookies 🧬
#topo2inhibitors #cardiotoxicity
Brian Dee (@bdeepharmd) 's Twitter Profile Photo

Join us virtually on Tuesday November 14th from 6-7:30 PM CST to learn more about MD Anderson’s pharmacy residency programs! We’ll have residents and leadership from all our programs available to chat. Registration link: forms.gle/Vamx7tPtZX1HWn…

Join us virtually on Tuesday November 14th from 6-7:30 PM CST to learn more about MD Anderson’s pharmacy residency programs! We’ll have residents and leadership from all our programs available to chat. Registration link: forms.gle/Vamx7tPtZX1HWn…
Contagion (@contagion_live) 's Twitter Profile Photo

The approval of the antifungal, isavuconazonium sulfate (Cresemba), is indicated for children as young as 1 year of age and the approval was based from 2 clinical trials. Astellas Pharma US contagionlive.com/view/fda-appro…

Mark Lewis, MD, FASCO (@marklewismd) 's Twitter Profile Photo

One of my patients (who labels himself a #PriorAuthSurvivor) diagrammed the unnecessary complexity of trying to get his medication approved on time 👇 Rinse & repeat and this is a cyclic nightmare that has nothing to do with chemo but rather the bureaucracy of US healthcare

One of my patients (who labels himself a #PriorAuthSurvivor) diagrammed the unnecessary complexity of trying to get his medication approved on time 👇

Rinse &amp; repeat and this is a cyclic nightmare that has nothing to do with chemo but rather the bureaucracy of US healthcare
Muhammad Hussain, MD (@whosainastro) 's Twitter Profile Photo

Why is p53 called p53? 🤔 A 🧵 about the history and discovery of the most studied gene in human history, also known as the guardian of the genome. 🧬 #pathtwitter #pathX #molecular #history

Julie Ann Justo (@julie_justo) 's Twitter Profile Photo

🚨Wow. Big news. First oral carbapenem, sulopenem (plus probenecid), just approved by the FDA for uUTI. 💊 Bring out the popcorn 🍿 This is gonna be interesting…. #IDtwitter SIDP ACCP INFD PRN IDSA globenewswire.com/news-release/2…

Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

1/ Sobering but important work in NEJM by Michael Scordo Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 et al: fatal case of enteric T-cell lymphoma following cilta-cel (#MMsm CAR-T) CAR integration into the TP53 locus. One of few papers that informs clinical discussions the moment it comes out. My two takeaways:

1/ Sobering but important work in <a href="/NEJM/">NEJM</a> by <a href="/MScordoMD/">Michael Scordo</a> <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a> et al: fatal case of enteric T-cell lymphoma following cilta-cel (#MMsm CAR-T) CAR integration into the TP53 locus.

One of few papers that informs clinical discussions the moment it comes out. My two takeaways:
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

BREAKING from NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection.

BREAKING from <a href="/NEJM/">NEJM</a> 
In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is :
🔘Noninferior to full-dose (5 mg BID) for VTE recurrence
🔘Lower bleeding risk (12.1% vs. 15.6%)
🔘Safer extended anticoagulation, same protection.